P

Inventor

CORTE JAMES R

US65 patents
⚠️ This page may combine multiple inventors who share the name “CORTE JAMES R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

43 patents
US10662172B2May 26, 2020

Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists

BRISTOL MYERS SQUIBB CO30 citations94
US10576062B2Mar 3, 2020

Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists

BRISTOL MYERS SQUIBB CO18 citations93
US10071078B2Sep 11, 2018

Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists

BRISTOL MYERS SQUIBB CO21 citations93
US9453018B2Sep 27, 2016

Pyrimidinones as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO13 citations92
US7626039B2Dec 1, 2009

Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO14 citations92
US7459564B2Dec 2, 2008

Substituted biaryl compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO26 citations92
US7453002B2Nov 18, 2008

Five-membered heterocycles useful as serine protease inhibitors

BRISTOL MYERS SQUIBB CO24 citations92
US7417063B2Aug 26, 2008

Bicyclic heterocycles useful as serine protease inhibitors

BRISTOL MYERS SQUIBB CO27 citations92
US7141578B2Nov 28, 2006

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO17 citations92
US7429604B2Sep 30, 2008

Six-membered heterocycles useful as serine protease inhibitors

BRISTOL MYERS SQUIBB CO35 citations90
US10487086B2Nov 26, 2019

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO3 citations84
US10208068B2Feb 19, 2019

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO5 citations84
US9902742B2Feb 27, 2018

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO5 citations84
US9802939B2Oct 31, 2017

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO3 citations84
US9611274B2Apr 4, 2017

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO5 citations84
US9108951B2Aug 18, 2015

Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO5 citations84
US7645799B2Jan 12, 2010

Substituted biaryl compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO7 citations74
US11136327B2Oct 5, 2021

Macrocycles as factor XIA inhibitors

BRISTOL MYERS SQUIBB CO1 citations73
US11053247B2Jul 6, 2021

Pyrimidinones as factor XIA inhibitors

BRISTOL MYERS SQUIBB CO2 citations72
US11007180B2May 18, 2021

Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists

BRISTOL MYERS SQUIBB CO3 citations72
US10336754B2Jul 2, 2019

Pyrimidinones as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO2 citations72
US9777001B2Oct 3, 2017

Macrocycles with aromatic P2′ groups as factor xia inhibitors

BRISTOL MYERS SQUIBB CO3 citations72
US10336730B2Jul 2, 2019

Substituted glycine derived FXIA inhibitors

BRISTOL MYERS SQUIBB CO1 citations63
US12428421B2Sep 30, 2025

Pyrimidinones as factor XIA inhibitors

BRISTOL MYERS SQUIBB CO0 citations62
US12404274B2Sep 2, 2025

Macrocycles as factor xia inhibitors

BRISTOL MYERS SQUIBB CO0 citations62
US12195444B2Jan 14, 2025

Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists

BRISTOL MYERS SQUIBB CO0 citations62
US11697646B2Jul 11, 2023

Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists

BRISTOL MYERS SQUIBB CO0 citations62
US11352345B2Jun 7, 2022

Cyclohexyl acid pyrazole azoles as LPA antagonists

BRISTOL MYERS SQUIBB CO1 citations62
US11319315B2May 3, 2022

Cyclohexyl acid triazole azoles as LPA antagonists

BRISTOL MYERS SQUIBB CO1 citations62
US11267800B2Mar 8, 2022

Cyclohexyl acid triazole azines as LPA antagonists

BRISTOL MYERS SQUIBB CO2 citations62
US11008300B2May 18, 2021

Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists

BRISTOL MYERS SQUIBB CO0 citations62
US10000466B2Jun 19, 2018

Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO1 citations62
US9453029B2Sep 27, 2016

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO2 citations62
US9079918B2Jul 14, 2015

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO2 citations62
US7842708B2Nov 30, 2010

Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO4 citations62
US7517904B2Apr 14, 2009

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO1 citations62
US7381730B2Jun 3, 2008

3-arylquinazoline derivatives as selective estrogen receptor beta modulators

BRISTOL MYERS SQUIBB CO2 citations62
US7105537B2Sep 12, 2006

2-substituted cyclic amines as calcium sensing receptor modulators

BRISTOL MYERS SQUIBB CO4 citations61
USRE49352EJan 3, 2023

Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists

BRISTOL MYERS SQUIBB CO0 citations60
US9745313B2Aug 29, 2017

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US9725435B2Aug 8, 2017

Substituted 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US9394276B2Jul 19, 2016

Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US9376444B2Jun 28, 2016

Dihydropyridone P1 as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO0 citations52

CORTE JAMES R

3 patents

HANGELAND JON J

2 patents

PINTO DONALD J P

1 patent

QUAN MIMI L

1 patent

Showing the top 50 of 65 patents by PatentIndex Score.